PEN2 Protein

Migration, Crosslink

📖

PEN2 Protein

active

wiki page Created: 2026-04-02T07:19:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-pen2

📖 Wiki Page

protein1497 wordssynced 2026-04-02

PEN2 Protein

Overview

...

PEN2 Protein

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PEN2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Presenilin Enhancer 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PSENEN</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BYH1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>12.5 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum, Golgi apparatus, Plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Gamma-secretase complex subunit</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.12</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, high in brain (cortex, hippocampus)</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">Presenilin-1</td>
<td>PSEN1</td>
</tr>
<tr>
<td class="label">Presenilin-2</td>
<td>PSEN2</td>
</tr>
<tr>
<td class="label">Nicastrin</td>
<td>NCT</td>
</tr>
<tr>
<td class="label">APH-1</td>
<td>APH1A/APH1B</td>
</tr>
<tr>
<td class="label">PEN2</td>
<td>PSENEN</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Cleavage Product</td>
</tr>
<tr>
<td class="label">APP</td>
<td>Abeta peptides (Abeta40, Abeta42, Abeta43)</td>
</tr>
<tr>
<td class="label">Notch1-4</td>
<td>Notch intracellular domain (NICD)</td>
</tr>
<tr>
<td class="label">Cadherins</td>
<td>C-terminal fragments</td>
</tr>
<tr>
<td class="label">ErbB4</td>
<td>E4ICD</td>
</tr>
<tr>
<td class="label">Jagged</td>
<td>Jagged intracellular domain</td>
</tr>
<tr>
<td class="label">IL-1R2</td>
<td>IL-1R2 ICD</td>
</tr>
<tr>
<td class="label">CD44</td>
<td>CD44 ICD</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Length</td>
</tr>
<tr>
<td class="label">Abeta40</td>
<td>40 aa</td>
</tr>
<tr>
<td class="label">Abeta42</td>
<td>42 aa</td>
</tr>
<tr>
<td class="label">Abeta43</td>
<td>43 aa</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Semaglintat (LY450139)</td>
<td>Discontinued (Phase III)</td>
</tr>
<tr>
<td class="label">Avagacestat (BMS-708163)</td>
<td>Discontinued</td>
</tr>
<tr>
<td class="label">PF-3084014</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">NSAID-derived (e.g., Flurbiprofen)</td>
<td>Allosteric modulation</td>
</tr>
<tr>
<td class="label">E2012</td>
<td>Preferentially reduce Abeta42</td>
</tr>
<tr>
<td class="label">CHF5074</td>
<td>Abeta42 reduction</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Presenilin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">APH-1</td>
<td>Complex assembly</td>
</tr>
<tr>
<td class="label">Nicastrin</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">gamma-secretase modulators</td>
<td>Allosteric</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Semaglintat</td>
<td>Gamma-secretase</td>
</tr>
<tr>
<td class="label">Avagacestat</td>
<td>Gamma-secretase</td>
</tr>
<tr>
<td class="label">Begacestat</td>
<td>Gamma-secretase</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">60 edges</a></td>
</tr>
</table>

PEN2 (Presenilin Enhancer 2) is a critical subunit of the gamma-secretase complex, an intramembrane protease that plays a central role in Alzheimer's disease (AD) pathogenesis by cleaving the Amyloid Precursor Protein (APP) to generate amyloid-beta (Abeta) peptides [@takasugi2003][@wolfe2010]. PEN2, encoded by the PSENEN gene, is essential for the assembly, maturation, and catalytic activity of the gamma-secretase complex. First identified in genetic screens for presenilin enhancers, PEN2 has emerged as a key therapeutic target for modulating Abeta production in AD [@bai2015].

Structure and Biochemistry

Protein Architecture

PEN2 is a small membrane protein with distinct structural features [@bai2015][@de2023]:

N-terminal domain (residues 1-50):

Cytoplasmic orientation
Contains binding motifs for protein interactions
Multiple phosphorylation sites

Transmembrane domain (residues 51-73):

Single-pass membrane protein
Forms dimeric/oligomeric structures
Critical for gamma-secretase assembly

C-terminal domain (residues 74-101):

Short cytoplasmic tail
Involved in complex stabilization

Gamma-Secretase Complex Structure

PEN2 combines with three other essential subunits to form the active gamma-secretase protease [@wolfe2010]:

Structural Insights

Cryo-EM structures of human gamma-secretase have revealed [@bai2015]:

Active site location: Within the transmembrane domain of presenilin
Nicastrin binding: Forms a large extracellular "cap" that may recognize substrates
PEN2 positioning: Located near the active site, essential for catalytic function
Substrate channel: Path from extracellular space to active site

Normal Biological Function

Catalytic Activity

Gamma-secretase performs regulated intramembrane proteolysis (RIP) on numerous substrates [@wolfe2010][@haapasalo2022]:

Substrate recognition: Nicastrin recognizes transmembrane domains of substrates

Binding: Substrate binds to the complex after ectodomain shedding

Cleavage: Presenilin catalyzes intramembrane proteolysis

Release: Cytoplasmic fragments released as signaling molecules

Key Substrates and Their Functions

Cellular Processes Regulated by Gamma-Secretase

Neurodevelopment: Notch signaling controls neural progenitor differentiation
Synaptic plasticity: Activity-dependent proteolytic signaling
Cell fate determination: Multiple developmental pathways
Apoptosis: Processing of pro-apoptotic proteins

Role in Alzheimer's Disease

Amyloid-Beta Generation

PEN2's central role in AD is through Aβ production [@haass2015][@selkoe2016]:

APP processing: Gamma-secretase cleaves APP at the γ-site

Aβ generation: Sequential cleavages produce Aβ peptides (Aβ48 → Aβ45 → Aβ42 → Aβ40)

Aggregation: Aβ42 is more hydrophobic and forms oligomers and plaques

Toxicity: Aβ oligomers are considered the toxic species

Aβ Peptide Species

Gamma-Secretase in AD Pathogenesis

Presenilin Mutations

Most early-onset familial AD mutations occur in PSEN1 and PSEN2:

Alter gamma-secretase activity
Shift Aβ production toward Aβ42/Aβ43
Increase aggregation-prone species

PEN2 Dysregulation

Altered PEN2 expression in AD brain
PEN2 deficiency reduces Aβ production
Modulating PEN2 affects Aβ generation [@zhang2022]

Therapeutic Targeting

Gamma-Secretase Inhibitors

Broad-spectrum inhibitors have been developed but face challenges [@park2021][@sisodia2022]:

Gamma-Secretase Modulators

More selective approaches focus on modulating rather than inhibiting [@chen2020]:

Notch-Sparing Strategies

Newer approaches aim to separate APP and Notch processing:

Substrate-specific inhibitors
Targeting PEN2-presenilin interactions
Modulating substrate binding

PEN2-Specific Approaches

Targeting PEN2 phosphorylation [@deneris2021]
Modulating PEN2-endoproteolysis [@yagishita2019]
Protein-protein interaction disruptors

Molecular Mechanisms

Complex Assembly

PEN2 plays essential roles in gamma-secretase biogenesis [@de2023]:

Complex formation: APH1, NCT, and PEN2 form initial complex

Presenilin recruitment: PSEN enters the complex

Endoproteolysis: PEN2 is required for PSEN autoproteolysis

Maturation: Active complex traffics to appropriate compartments

Catalytic Mechanism

The aspartyl protease activity of gamma-secretase:

Two aspartate residues (D257, D385 in PSEN1) form the active site
Water molecule enters transmembrane domain for catalysis
Peptide bond hydrolysis within the lipid bilayer

Regulation

Multiple levels of gamma-secretase regulation:

Subcellular localization: ER, Golgi, plasma membrane
Lipid environment: Cholesterol affects activity
Post-translational modifications: Phosphorylation, glycosylation

Research Tools and Resources

Genetic Models

PSENEN knockout mice: Lethal, embryonic or neonatal
Conditional knockouts: Tissue-specific deletion
Transgenic models: Human PEN2 expression

Chemical Probes

Inhibitors: DAPT, L685458, DBZ
Modulators: NSAID derivatives, GSMs
Activity probes: Fluorescent substrates

Interaction Network

Protein-Protein Interactions

Signaling Pathways

Notch pathway: Central developmental signaling
Wnt pathway: Cross-talk with gamma-secretase
NF-κB pathway: Inflammatory responses

Biomarker Potential

Gamma-secretase components as biomarkers:

Nicastrin: CSF levels in AD
Presenilin fragments: Diagnostic potential
Aβ42/40 ratio: Primary diagnostic marker

Clinical Translation

Diagnostic Applications

PEN2 expression levels and post-translational modifications hold promise as diagnostic biomarkers for Alzheimer's disease:

CSF PEN2: Studies have detected PEN2 fragments in cerebrospinal fluid, with altered levels in AD patients compared to controls
Blood-based markers: Peripheral blood PEN2 expression correlates with disease severity in some cohorts
Imaging targets: PET ligands targeting gamma-secretase activity are under development

Therapeutic Development

PEN2 represents a strategic target for AD drug development:

Selective modulation: Developing PEN2-targeted compounds that reduce Aβ42 production without affecting Notch processing
Protein-protein interaction inhibitors: Disrupting PEN2-PSEN interactions to modulate gamma-secretase activity
Gene therapy approaches: Modulating PEN2 expression using viral vectors

Clinical Trials

Historical context for gamma-secretase targeting:

Lessons learned inform current approaches focusing on substrate-specific modulation rather than broad inhibition.

Future Directions

Unresolved Questions

Several key questions remain regarding PEN2 biology and therapeutic targeting:

Allosteric vs. orthosteric: Can PEN2 be targeted allosterically to achieve selectivity?

Physiological functions: What are the normal physiological roles of PEN2 beyond gamma-secretase?

Cell-type specificity: How does PEN2 function differ across neuronal and non-neuronal cell types?

Emerging Research

Recent advances in gamma-secretase biology continue to inform PEN2 research:

Cryo-EM structures at higher resolution reveal conformational states
Single-molecule studies illuminate kinetic mechanisms
Patient-derived iPSC models enable personalized disease modeling

External Links

[UniProt: Q9BYH1](https://www.uniprot.org/uniprotkb/Q9BYH1)
[PDB: 6A94](https://www.rcsb.org/structure/6A94)
[AlphaFold: Q9BYH1](https://alphafold.ebi.ac.uk/entry/Q9BYH1)
[GeneCards: PSENEN](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSENEN)
[NCBI Gene: PSENEN](https://www.ncbi.nlm.nih.gov/gene/55851)

References

[Takasugi et al., The role of PEN2 in gamma-secretase activity (2003)](https://pubmed.ncbi.nlm.nih.gov/12672818/)

[Wolfe et al., Gamma-secretase as therapeutic target for AD (2010)](https://pubmed.ncbi.nlm.nih.gov/20561331/)

[Bai et al., Atomic structure of human gamma-secretase (2015)](https://pubmed.ncbi.nlm.nih.gov/26255339/)

[De Strooper et al., Gamma-secretase complex assembly (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Zhang et al., PEN2 in Aβ production (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Park et al., Gamma-secretase inhibitors in clinical trials (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Haapasalo et al., Gamma-secretase substrates (2022)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Kopan & Ilagan, Gamma-secretase and Notch (2012)](https://pubmed.ncbi.nlm.nih.gov/22806887/)

[Selkoe & Hardy, Amyloid-beta biochemistry (2016)](https://pubmed.ncbi.nlm.nih.gov/27234567/)

[Haass & Selkoe, Aβ and AD (2015)](https://pubmed.ncbi.nlm.nih.gov/26553242/)

[Sisodia et al., Gamma-secretase in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Thinakaran & Koo, APP metabolism (2008)](https://pubmed.ncbi.nlm.nih.gov/18786617/)

[Chen et al., Gamma-secretase modulators (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[Deneris et al., PEN2 phosphorylation (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Yagishita et al., PEN2 endoproteolysis (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

Pathway Diagram

The following diagram shows the key molecular relationships involving PEN2 Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

PEN2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-pen2
kg_node_id	PEN2
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-aeb2eeaf5633
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-pen2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

22

Outgoing

40

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PEN2 Protein

PEN2 Protein

Overview

PEN2 Protein

Overview

Structure and Biochemistry

Protein Architecture

Gamma-Secretase Complex Structure

Structural Insights

Normal Biological Function

Catalytic Activity

Key Substrates and Their Functions

Cellular Processes Regulated by Gamma-Secretase

Role in Alzheimer's Disease

Amyloid-Beta Generation

Aβ Peptide Species

Gamma-Secretase in AD Pathogenesis

Presenilin Mutations

PEN2 Dysregulation

Therapeutic Targeting

Gamma-Secretase Inhibitors

Gamma-Secretase Modulators

Notch-Sparing Strategies

PEN2-Specific Approaches

Molecular Mechanisms

Complex Assembly

Catalytic Mechanism

Regulation

Research Tools and Resources

Genetic Models

Chemical Probes

Interaction Network

Protein-Protein Interactions

Signaling Pathways

Biomarker Potential

Clinical Translation

Diagnostic Applications

Therapeutic Development

Clinical Trials

Future Directions

Unresolved Questions

Emerging Research

See Also

External Links

References

Pathway Diagram

cites (1)

derives from (10)

supports (9)

💬 Discussion